Acetylsalicylic acid Recruiting Phase 4 Trials for Stroke / Atrial Fibrillation (AF) Prevention

RecruitingPrevention4 IdentifierTitleDrugs
NCT01938248Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
NCT02168829Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
NCT03463317Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
NCT03073850Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation